Compare Cigna Corp (CI) vs Rivian Automotive, Inc. (RIVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Rivian Automotive, Inc. — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Rivian Automotive, Inc. trades at $16.4 (market cap $23.73B). The key difference: Cigna Corp is far larger — about 3.1× Rivian Automotive, Inc.'s market cap, and Cigna Corp pays a 2.24% dividend while Rivian Automotive, Inc. pays none. Which is the better fit depends on your goals.
| CI | RIVN | |
|---|---|---|
Market Cap | $73.56B | $23.73B |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $22.45 |
52-Week Low | $244.41 | $11.97 |
Enterprise Value | $98.27B | $23.77B |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Rivian Automotive (RIVN) trades at $16.00, up 4.03% today, with a bullish technical signal and support at $15–16. The company reported Q2 2026 EPS of -$0.47, beating estimates, and raised 2026 delivery guidance to 65,000–70,000 vehicles. Revenue grew to $5.39B in 2025, but net losses persist at -$3.65B, with cash flow negative. Analyst consensus is mixed, with a $18.70 price target and 48% buy ratings.
Outlook hinges on R2 SUV ramp-up and cost controls, with potential for margin improvement by late 2026. Key risks include high cash burn, execution delays, and EV market competition. Upside exists if profitability targets are met, but investors face volatility amid funding needs and sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Rivian Automotive, Inc.
Rivian Automotive, Inc. is an automotive technology company. The Company designs and manufactures vans, trucks, and sports utility vehicles, as well as offers repair and maintenance services. Rivian Automotive serves customers in North America and the United Kingdom.
Read more on RIVN →
